Officially Finding New Strains of Enzymes Leading to Suicidal Behavior

This article examines Officially Finding New Strains of Enzymes Leading to Suicidal Behavior. It presents the main facts, practical implications, and key points in a clearer, easier-to-follow format.

Understanding Officially Finding New Strains of Enzymes Leading to Suicidal Behavior

Each year, about 42,000 deaths in the United States and suicide are among the top 10 fatal groups. And now, a new medical door, in other words, a new controlled drug will be born when Dr. Lena Brundin of the Center for Neuroscience at the Andel Research Institute in Grand Rapids, MI said. he and his team found a. multidisciplinary enzyme in the brain that regulates suicidal behavior in humans. .

This new enzyme, called science ACMSD enzyme, can control two types of acid in the brain, leading to rapid suicidal behavior.

To get this result, Dr. Lena Brundin and his team selected 300 individuals from Sweden, some of whom had the intention to commit suicide and end their lives. These patients were conducted for research and testing of blood, spinal fluid, brain fluid, and genetic genes.

Photo source: internet.

The results showed that those who had intended to commit suicide often had erratic levels of two. picolinic and quinolinic acid acids in it, the amount of picolinic acid dropped too low, but the concentration of quinolinic acid was too high, causing the person to tend to commit suicide quickly.

And the research team showed that if you can make an inhibitor of ACMSD enzyme, you can control two brain acids that cause suicidal behavior in humans because these two types of brain acids depend on the enzyme. Multi-system ACMSD.

This research has just been published in Translational Psychiatry Magazine.

Huynh Dung (According to Medicalnewstoday)